JAIC
STLNW

Josh Arnold Investment Consultant’s Starling Oncology, Inc. Warrant STLNW Stock Holding History

Josh Arnold Investment Consultant’s Portfolio STLNW Stock Details STLNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-417,745
Closed -$62.9K – 25
2023
Q4 		$62.9K Buy
417,745
+27,704
+7% +$4.38K 0.06% 22
2023
Q3 		$35.1K Buy
+390,041
New +$31.7K 0.04% 23

Other funds holding STLNW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
FL
FreeGulliver LLC New Orleans, Louisiana $237M AUM 21.92% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Josh Arnold Investment Consultant's STLNW Position: Q1 2024 in Review

Josh Arnold Investment Consultant sold out of Starling Oncology, Inc. Warrant (STLNW) in Q1 2024, closing a stake of 417,745 shares — an estimated $62.9K sold.

Josh Arnold Investment Consultant first reported a position in STLNW in Q3 2023 and held it in 2 quarters. The position peaked at $62.9K in Q4 2023. 15 funds tracked by Wall St. Rank hold STLNW as of Q1 2024.

  • Josh Arnold Investment Consultant reported no remaining Starling Oncology, Inc. Warrant position as of Q1 2024 after selling out during the quarter.
  • Josh Arnold Investment Consultant sold 417,745 Starling Oncology, Inc. Warrant shares in Q1 2024, an estimated $62.9K.
  • Josh Arnold Investment Consultant first reported a position in Starling Oncology, Inc. Warrant in Q3 2023 and held it in 2 quarters.
  • Josh Arnold Investment Consultant's Starling Oncology, Inc. Warrant position peaked at $62.9K in Q4 2023.
  • 15 funds tracked by Wall St. Rank held Starling Oncology, Inc. Warrant as of Q1 2024.

Based on Josh Arnold Investment Consultant's 13F filing for Q1 2024, filed 15 May 2024.